Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets. The analysis for hematologic disorders is related to disease monitoring, prognosis, diagnosis, and screening.
Read Report Overview – https://www.transparencymarketresearch.com/hematology-diagnostics-market.html
Rise in prevalence of blood disorders, technological advancements and introduction of new technically advanced fully automated hematology analyzers, significant demand for laboratory automation, and increase in consolidation among market players and diagnostic laboratories are key factors that are expected to drive the global hematology diagnostics market during the forecast period.
The hematology diagnostics market can be segmented based on product type, which includes hematology instruments and hematology consumables. In terms of revenue, the global hematology diagnostics market was valued at approximately US$ 3,495.0 Mn in 2017 and is anticipated to reach approximately US$ 5,586.4 Mn by 2026, expanding at a CAGR of more than 5.0% from 2018 to 2026. The expansion of hematology consumables segment is likely to fuel the growth of global hematology diagnostics from 2018 to 2026.
Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8848
Rapid expansion of the global hematology diagnostics market is attributed to the increase in prevalence of blood disorders. Rise in awareness about these disorders among health care professionals and patients is projected to increase the demand for hematology diagnostics. For instance, approximately every three minutes, one person in the U.S. is diagnosed with blood cancer. Nearly 172,910 people in the U.S. were diagnosed with leukemia, lymphoma, or myeloma, in 2017. New cases of leukemia, lymphoma, and myeloma are expected to account for 10.2% of the estimated 1,688,780 new cancer cases diagnosed in the U.S. in 2017. An estimated 1,290,773 people in the U.S. are either living with, or are in remission from, leukemia, lymphoma, or myeloma.
Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=8848
Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow. Combination of these technologies has increased the yield and productivity of test results. Test volume, i.e. number of tests performed, is projected to increase owing to technological advances in disease diagnosis and the rise in demand for preventive diagnosis and treatment monitoring. This is also augmenting the demand for hematology analyzers with high throughput. Such technological revolution in hematology testing is expected to propel the market during the forecast period.
Hematology diagnostics market is witnessing expansion. Key market players such as Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., and Beckman Coulter, Inc. have a strong presence in the global hematology diagnostics market. The global hematology diagnostics market has witnessed high investments by various multinational manufacturers such, Abbott Laboratories, Sysmex Corporation and F. Hoffmann-La Roche Ltd in the last few years. The hematology diagnostics market is driven by significant demand for laboratory automation and consolidation in order to improve precision and efficiency, and advancement in technology leading to easy usage. For example, in April 2018, Danaher (Beckman Coulter, Inc.) received CE Mark of its DxH 520 hematology analyzer, which is designed to help physician office laboratories. Another example, in January 2017, Roche announced the launch of the new, hematology testing solution, the Cobas m 511 integrated hematology analyzer. Cobas m 511, uses a unique approach through patented Bloodhound technology for printing, staining, and imaging.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=8848
The global hematology diagnostics has been segmented based on product type, end-user, and geography. Based on product type, the market has been split into hematology instruments and hematology consumables. The hematology consumables segment led the market and is expected to continue its dominance during the forecast period. Factors such as rise in awareness of blood disorders among health care professionals and patients are projected to increase the demand for hematology analyzers and consumables. The hematology instruments segment is likely to lose market share during the forecast period. Among the hematology instruments segment, hematology analyzers were the leading sub-segment in 2017. The sub-segment is likely to account for a leading share of the segment of the market during the forecast period. Among the hematology consumables segment, reagents segment was the leading sub-segment in year 2017. It is and anticipated to dominate the segment of the market during the forecast period.
In terms of geography, North America held a major share of the global hematology diagnostics market in 2017. Technological advancements in instruments, ease of usage, and favorable reimbursement scenario drives the hematology diagnostics market in the region. The U.S. and Canada are rapidly advancing the frontiers of research and technological development as well as setting stringent standards for analysis of blood products quality. This, in turn, is likely to propel the hematology diagnostics market in North America during the forecast period. Asia Pacific is witnessing rapid development. High per capita income has increased utilization of diagnostic and therapy products in the region. Rapid expansion of the market in the region can be attributed to numerous government initiatives undertaken to improve the health care infrastructure. Development of health care infrastructure, rise in population, boom in the biotechnology industry, and increase in burden of diseases requiring diagnostic tests are propelling the hematology diagnostics market in Latin America and Middle East & Africa.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=8848
Key companies operating in the global hematology diagnostics and profiled in the report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., and Beckman Coulter, Inc. These players are adopting advanced techniques to develop hematology diagnostics and in order to expand their product offerings, strengthen their geographical reach, increase customer base, and garner market share. For instance, in June 2017, Abbott Laboratories announced the availability of Sekisui’s CP3000 coagulation analyzer in Europe, the Middle East, and Asia Pacific. In another instance, in March 2015, the diagnostics division of Siemens Healthineers launched three new scalable hematology systems: ADVIA 360 System, ADVIA 560 System, and ADVIA 560 AL System.
More Trending Reports by Transparency Market Research –
Medical Lifting Slings Market: The medical lifting slings market outlook predicts the market to rise at a CAGR of 6.7% during the forecast period, from 2022 to 2031.
Downstream Processing Market: The downstream processing market is expected to cross US$ 25.4 Bn by the end of 2030 at a CAGR of ~13%.
In-vitro Transcription Templates Market: Increase in acceptance of personalized medicine by healthcare providers is projected to drive the global in-vitro transcription templates market
In Vitro Fertilization Test Market: The global in vitro fertilization test market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of 6.1% from 2021 to 2031.
Cell & Tissue Preservation Market: The cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031.
Platelet Rich Plasma Market: The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period.
Biologics Contract Manufacturing Market: The Asia Pacific biologics contract manufacturing market is expected to register a CAGR of 14.5% during the forecast period.
Europe Direct-to-Consumer Laboratory Testing Market: The Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com